Antitrypanosomal therapy for Chagas disease: A single center experience with adverse drug reactions and strategies for enhancing treatment completion
Katherine Reifler(Boston University), Daniel Bourque(Boston University), Samantha Hall(Center for Disease Analysis), Madolyn Dauphinais(Boston University), Alejandra Salazar(Boston University), Alyse Wheelock(Henry M. Jackson Foundation), Elizabeth D. Barnett(Boston Medical Center), Davidson H. Hamer(Boston University), Michael Maiullari(Boston University), Helen West(University of Nottingham), Samuel Roytburd(Boston University), Ashley Maldonado(Boston Children's Hospital), Julia R. Köhler(Boston Children's Hospital), Deepa M. Gopal(Boston University)
Cited by 1
Related Papers
Management of Neonates Born at ≥35 0/7 Weeks’ Gestation With Suspected or Proven Early-Onset Bacterial Sepsis
|PEDIATRICS|2018|462
Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle
|PLoS Pathogens|2010|427
Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study
|The Lancet Global Health|2018|344
Management of Neonates Born at ≤34 6/7 Weeks’ Gestation With Suspected or Proven Early-Onset Bacterial Sepsis
|PEDIATRICS|2018|318
Adverse event reports following yellow fever vaccination
|Vaccine|2008|278